Published in:
Open Access
01-02-2011 | Research
Hormonal status in protracted critical illness and in-hospital mortality
Authors:
Tarek Sharshar, Sylvie Bastuji-Garin, Andrea Polito, Bernard De Jonghe, Robert D Stevens, Virginie Maxime, Pablo Rodriguez, Charles Cerf, Hervé Outin, Philippe Touraine, Kathleen Laborde, the Groupe de Réflexion et d'Etude des Neuromyopathies En Réanimation
Published in:
Critical Care
|
Issue 1/2011
Login to get access
Abstract
Introduction
The aim of this study was to determine the relationship between hormonal status and mortality in patients with protracted critical illness.
Methods
We conducted a prospective observational study in four medical and surgical intensive care units (ICUs). ICU patients who regained consciousness after 7 days of mechanical ventilation were included. Plasma levels of insulin-like growth factor 1 (IGF-1), prolactin, thyroid-stimulating hormone, follicle-stimulating hormone, luteinizing hormone, estradiol, progesterone, testosterone, dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS) and cortisol were measured on the first day patients were awake and cooperative (day 1). Mean blood glucose from admission to day 1 was calculated.
Results
We studied 102 patients: 65 men and 37 women (29 of the women were postmenopausal). Twenty-four patients (24%) died in the hospital. The IGF-1 levels were higher and the cortisol levels were lower in survivors. Mean blood glucose was lower in women who survived, and DHEA and DHEAS were higher in men who survived.
Conclusions
These results suggest that, on the basis of sex, some endocrine or metabolic markers measured in the postacute phase of critical illness might have a prognostic value.